In a clinical trial, 30 sickle cell anemia patients are randomly assigned to two groups. One group receives the currently marketed medicine, and the other group receives an experimental medicine. Each week, patients report to the clinic where blood tests are conducted. The lab technician is unaware of the kind of medicine the patient is taking. This design can be described as